About the Registry
The National Registry of Drug-Induced Ocular Side Effects was founded in 1976 and was initially funded by the Federal Food and Drug Administration. The Registry is supported by the Casey Eye Institute at Oregon Health and Science University and the American Academy of Ophthalmology. The goal is to maintain an international clearinghouse of information on adverse ocular events associated with drugs, chemicals and herbals. The underlying principle of the Registry is to generate early signals of adverse ocular reactions. The data is available to clinicians and researchers and is published in both peer review journals and every 4-5 years in a book titled Drug-Induced Ocular Side Effects. The 8th edition of Drug-Induced Ocular Side Effects will be available June 2020.
In addition to collecting spontaneous reports from clinicians, the Registry accumulates data from spontaneous reports sent to the World Health Organization's Uppsala Monitoring Center (Uppsala, Sweden), the Food and Drug Administration (Rockville, MD), pharmaceutical companies, and screening of the world's literature.
All case reports are welcome.
In addition to collecting spontaneous reports from clinicians, the Registry accumulates data from spontaneous reports sent to the World Health Organization's Uppsala Monitoring Center (Uppsala, Sweden), the Food and Drug Administration (Rockville, MD), pharmaceutical companies, and screening of the world's literature.
All case reports are welcome.
